EPAS1 Antikörper (AA 584-870)
Kurzübersicht für EPAS1 Antikörper (AA 584-870) (ABIN2722736)
Target
Alle EPAS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 584-870
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Human recombinant protein fragment corresponding to amino acids 584-870 of human EPAS1 (NP_001421) produced in E.coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB 1:2000, IHC 1:150,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 4.02 mg/mL
-
-
-
: "A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review." in: Endocrine pathology, Vol. 28, Issue 1, pp. 75-82, (2017) (PubMed).
-
: "A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review." in: Endocrine pathology, Vol. 28, Issue 1, pp. 75-82, (2017) (PubMed).
-
- EPAS1 (Endothelial PAS Domain Protein 1 (EPAS1))
-
Andere Bezeichnung
- EPAS1
-
Molekulargewicht
- 96.3 kDa
-
NCBI Accession
- NM_001430
-
HGNC
- 2034
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2, Warburg Effekt
Target
-